These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8983343)

  • 21. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.
    Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M
    Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
    J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.
    Elsinga PH; Franssen EJ; Hendrikse NH; Fluks L; Weemaes AM; van der Graaf WT; de Vries EG; Visser GM; Vaalburg W
    J Nucl Med; 1996 Sep; 37(9):1571-5. PubMed ID: 8790221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
    Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
    J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
    Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH
    Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.
    Evers R; Kool M; Smith AJ; van Deemter L; de Haas M; Borst P
    Br J Cancer; 2000 Aug; 83(3):366-74. PubMed ID: 10917553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion.
    Batrakova EV; Li S; Elmquist WF; Miller DW; Alakhov VY; Kabanov AV
    Br J Cancer; 2001 Dec; 85(12):1987-97. PubMed ID: 11747344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
    Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
    Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
    Sharma AK; Zhang L; Li S; Kelly DL; Alakhov VY; Batrakova EV; Kabanov AV
    J Control Release; 2008 Nov; 131(3):220-7. PubMed ID: 18722489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin.
    Yang X; Pagé M
    Oncol Res; 1995; 7(12):619-24. PubMed ID: 8704279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
    Batrakova EV; Kelly DL; Li S; Li Y; Yang Z; Xiao L; Alakhova DY; Sherman S; Alakhov VY; Kabanov AV
    Mol Pharm; 2006; 3(2):113-23. PubMed ID: 16579640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD; Carmeli S; Moore RE; Patterson GM
    Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z; Yuan S; Hao J; Fang X
    Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric double labeling technique for screening of multidrug resistance.
    Gheuens EE; van Bockstaele DR; van der Keur M; Tanke HJ; van Oosterom AT; De Bruijn EA
    Cytometry; 1991; 12(7):636-44. PubMed ID: 1685985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity.
    Batrakova EV; Dorodnych TY; Klinskii EY; Kliushnenkova EN; Shemchukova OB; Goncharova ON; Arjakov SA; Alakhov VY; Kabanov AV
    Br J Cancer; 1996 Nov; 74(10):1545-52. PubMed ID: 8932333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wang B; Wu M; Perchellet EM; McIlvain CJ; Sperfslage BJ; Huang X; Tamura M; Stephany HA; Hua DH; Perchellet JP
    Int J Oncol; 2001 Dec; 19(6):1169-78. PubMed ID: 11713586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells.
    Batrakova E; Lee S; Li S; Venne A; Alakhov V; Kabanov A
    Pharm Res; 1999 Sep; 16(9):1373-9. PubMed ID: 10496652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.